General information about company

Scrip code524322
NSE SymbolNOTLISTED
MSEI SymbolNOTLISTED
ISININE323K01017
Name of the entityKABRA DRUGS LIMITED
Date of start of financial year01-04-2024
Date of end of financial year31-03-2025
Reporting Quarter TypeYearly
Date of Quarter Ending31-03-2025
Type of companyEquity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity?NoReg. 15(2) of SEBI (LODR) Regulations, 2015, Corporate Governance is not applicable to our Company and accordingly, Corporate Governance report is not required to be submitted, under regulation 27(2) of SEB! (LODR) Regulations, 2015 for quarter and year ended 31 March, 2025.
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity?Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity?NoNo acquisition made during the quarter ended 31st March 2025
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity?NoNo imposition of fine or penalty during the quarter ended 31st March 2025
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity?NoNo updates or disputed tax dues or litigations during the quarter ended 31st March 2025
Whether Annexure I (Part F) of the SEBI Circular dated December 31, 2024 related to Disclosure Of Loans / Guarantees / Comfort Letters / Securities Etc. is Applicable to the entity?NoNot applicable
Is SCORE ID Available ?Yes
SCORE Registration IDK00006
Reason For No SCORE ID
Type of SubmissionOriginal
Remarks (website dissemination)
Remarks for Exchange (not for Website Dissemination)



Investor Grievance Details

No. of investor complaints pending at the beginning of Quarter0
No. of investor complaints received during the Quarter1
No. of investor complaints disposed off during the Quarter1
No. of investor complaints those remaining unresolved at the end of the Quarter0